OxySure (OXYS) Announces Products Available in MSC Industrial “Big Book” and on mscdirect.com
Frisco, Texas, USA, June 10, 2014 – OxySure Systems, Inc. (OXYS: OTCQB) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology is pleased to announce its products are now immediately available on mscdirect.com, to be followed by insertion in MSC Industrial’s “Big Book.” This includes the OxySure Model 615 emergency oxygen device, replacement cartridges, thermal bags, pulse oximeters and other respiratory and emergency medical products.
The OxySure Model 615 enables lay persons, from bystanders to work colleagues, to administer medical oxygen easily and quickly in any medical emergency, while waiting for paramedics or first responders to arrive on the scene. Model 615 is particularly suited as a companion product to Automated External Defibrillators (AEDs), and is FDA cleared for over the counter purchase.
“We are pleased to be represented on mscdirect.com and in the MSC Industrial catalog,” said Julian T. Ross, CEO of OxySure. “Our products can enable good outcomes and even save lives in medical emergencies in industrial settings such as manufacturing facilities and commercial environments all over America.”
About MSC Industrial Supply Co.
MSC Industrial Supply Co. is one of the largest distributors of metalworking and maintenance, repair and operations (“MRO”) supplies to industrial customers throughout the United States. MSC employs one of the industry’s largest sales forces and distributes approximately 600,000 industrial products from approximately 3,000 suppliers. In-stock availability is approximately 99%, with next day standard delivery to the contiguous United States on qualifying orders up until 8 p.m. Eastern Time. For more information, visit MSC’s website at mscdirect.com.
About OxySure Systems, Inc.
OxySure Systems, Inc. (OTCQB : OXYS) is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure’s products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other “Immediately Dangerous to Life or Health” (IDLH) environments. www.OxySure.com
Forward-Looking Statements
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts, including, without limitation, statements that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development, may be deemed to be forward-looking statements. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import also identify forward-looking statements. These statements are subject to risks and uncertainties. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. Except as may be required under applicable law, we assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of OxySure Systems, Inc. can be found in the filings of OxySure Systems, Inc. with the U.S. Securities and Exchange Commission.
Investor Contact:
Stonegate Securities, Inc.
214-987-4121 / 972-294-6461
Media Contact:
Tags: